CROMSOURCE Acquires Pleiad: Expands US Coverage


Company News Release

CROMSOURCE, an international full service contract research organization (CRO) announced the acquisition of Pleiad, an international CRO with offices in the United States (Cambridge, Mass.) and United Kingdom (Stirling, Scotland).

Pleiad was launched in 1999, supporting clients in multiple therapy areas and with dedicated Medical Device and Ophthalmology Divisions. Additionally,Pleiad also encompasses particularly strong capabilities within statistics and data management.

"We are delighted to welcome Pleiad and its expert team," stated Dr Oriana Zerbini, Chief Executive Officer of CROMSOURCE. "For some time we have wanted to expand and consolidate our presence in the United States and we have now found the perfect way to do so. The opportunity to further add to our UK team and expand our team of experts in data management and statistics is also of great importance to us. With this collaboration CROMSOURCE reinforces its capability to support our clients with even the largest of development programmes in both Europe and the United States."

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.